logo
Share SHARE
FONT-SIZE Plus   Neg

Anthera Pharma Prices $40 Mln Stock Offering

Anthera Pharmaceuticals, Inc. (ANTH) said Friday that it has priced an underwritten public offering of about 60.6 million shares of its common stock, offered at a price of $0.66 per share.

The company estimates that the gross proceeds from the offering, before deducting underwriting discounts and commissions and other estimated offering expenses payable by Anthera, will be $40.0 million.

In addition, the company has granted the underwriters a 30-day option to purchase up to an additional about 9.1 million shares of common stock.

The offering is expected to close on or about January 30.

The company plans to use the net proceeds from the offering for general corporate purposes.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
The holiday throng seeking to take a flight out to their preferred destinations at the at New York's Kennedy International Airport ahead of the Memorial Day holiday were in for a rude shock. Technology played a spoilsport, as a computer system broke down Sunday evening at a terminal, causing flight delays and cancellations that resulted in manual check-in process for thousands of holiday passeng The month of May saw the FDA greenlight 5 new drugs, including 1 new molecular entity, and surprisingly turn down 1 drug candidate, whose approval was considered a no-brainer by some experts. Lab equipment maker Thermo Fisher Scientific Inc. has agreed to acquire electron microscope maker FEI Co. for about $4.2 billion in cash, the two companies said Friday. Thermo Fisher noted that FEI's electron microscopy platform will complement its own mass spectrometry systems to accelerate advancements in structural biology.
comments powered by Disqus
Follow RTT